Now Available: Easy, Free Care for COVID-19
Request a virtual visit with a clinician to see if Paxlovid or Molnupiravir is right for you. Paxlovid and Molnupiravir are pills that can help treat COVID-19. If it’s right for you, you can get your prescription through home delivery or pharmacy pickup. There is no cost for this service offered by the Commonwealth of Massachusetts.
Get a virtual visit with a licensed clinician
- If you’re eligible, you’ll have a consultation with a clinician to see if antiviral treatment is right for you. You can select a video or phone call.
- For a video consultation, youâll only need a smartphone or computer with video capabilities. No special software is required.
- Your consultation will be confidential in accordance with applicable medical privacy laws. You can view our consent for healthcare services.
Youâll need to provide some health information
- Youâll need to have tested positive for COVID-19 and had your first symptom in the last 5 days. You wonât need to upload a positive COVID-19 test.
- If you have a kidney disease, youâll need to upload a copy of lab results from the last 3 months.
What’s Paxlovid?
Paxlovid has been authorized for emergency use by FDA under an EUA, for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 88 lbs) with positive results of direct SARS CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death.
If Paxlovid is right for you, treatment should start as soon as possible after COVID-19 diagnosis and your first symptom in the last 5 days. Paxlovid is not for people who have a history of allergy to nirmatrelvir or ritonavir or other components of these drugs, and it is not for people taking certain other drugs. Paxlovid may cause side effects, some of which may be serious and unexpected. Learn more about Paxlovid on the manufacturerâs website, and review the patient and healthcare provider fact sheets for more information.
The emergency use of Paxlovid is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID19 pandemic under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization revoked sooner.
What’s Molnupiravir?
Molnupiravir is authorized for emergency use by FDA under an EUA to treat mild-to-moderate COVID-19 in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19 including hospitalization or death, and for whom other COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically appropriate.
Molnupiravir isn’t authorized for use in people less than 18 years of age, for prevention of COVID-19, for people needing hospitalization for COVID-19, or for use for longer than 5 consecutive days. Molnupiravir isn’t recommended for use in pregnancy as it may cause harm to an unborn baby. Molnupiravir may cause side effects, some of which may be serious and unexpected. Learn more about Molnupiravir on the manufacturer’s website and review the patient and healthcare provider fact sheets for more information.
The emergency use of Molnupiravir is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization revoked sooner.
Trademarks referenced herein held by their respective owners.
